NURSING 6005 CHAPTER 59: DRUGS RELATED TO HYPOTHALAMIC AND PITUITARY FUNCTION Test Bank

NURSING 6005 CHAPTER 59: DRUGS RELATED TO HYPOTHALAMIC AND PITUITARY FUNCTION Test Bank MULTIPLE CHOICE 1. A child with Prader-Willi syndrome (PWS) has short stature, and the provider is considering treatment with growth hormone. Which aspect of this child’s history should the nurse report to the provider? a. Behavior problems b. Low muscle tone c. Mental impairment d. Sleep apnea ANS: D Growth hormone must be avoided in patients with PWS who are severely obese, who have a history of upper airway obstruction or sleep apnea, or who have severe respiratory impairment because of a risk of sudden death associated with these disorders. Behavior problems, low muscle tone, and mental impairment are commonly associated with PWS and are not contraindications to treatment with growth hormone. DIF: Cognitive Level: Application REF: Growth Hormone | Therapeutic Uses | Pediatric Short Stature Associated with Prader-Willi Syndrome TOP: Nursing Process: Assessment MSC: NCLEX Client Needs Category: Physiologic Integrity: Reduction of Risk Potential 2. A nurse is providing teaching for a nondiabetic adult who develops growth hormone deficiency and who will begin treatment with somatropin (Humatrope). Which statement by the patient indicates understanding of the teaching? a. “Intramuscular dosing is more effective than subcutaneous dosing.” b. “I will have increased muscle mass and strength as well as increased height.” c. “I will need to monitor my blood pressure frequently while taking this drug.” d. “I will need to take insulin while using this, because it causes hyperglycemia.” ANS: C Growth hormone in adults causes an increase in systolic blood pressure, so patients should be taught to monitor blood pressure while taking the drug. Subcutaneous dosing is as effective as IM dosing and is preferred, because it is less painful. Although muscle mass will increase, strength and height will not. Growth hormone is diabetogenic but causes significant problems in patients with pre-existing diabetes. DIF: Cognitive Level: Application REF: Growth Hormone | Therapeutic Uses | Adult-Onset Growth Hormone Deficiency | Adverse Effects and Interactions | Hyperglycemia | Administration TOP: Nursing Process: Planning MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 3. A 7-year-old child who is otherwise healthy is receiving mecasermin (Increlex) replacement therapy to treat severe primary deficiency of insulin-like growth factor-1 (IGF-1). The child develops tonsillar hypertrophy. The nurse anticipates that the provider will recommend: a. antibiotics.